Zymeworks outlines $1.5B milestone potential and signals milestone-driven expansion strategy through 2028
Source: SeekingAlpha
2026-03-02 21:19:18 ET
More on Zymeworks
- Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
- Zymeworks Inc. 2025 Q4 - Results - Earnings Call Presentation
- Zymeworks Inc. (ZYME) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Zymeworks GAAP EPS of -$0.55 misses by $0.21, revenue of $2.52M misses by $18.01M
- Zymeworks Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Zymeworks outlines $1.5B milestone potential and signals milestone-driven expansion strategy through 2028
Zymeworks Inc.
NASDAQ: ZYME
ZYME Trading
-5.24% G/L:
$25.15 Last:
323,159 Volume:
$25.09 Open:
ZYME Latest News
March 02, 2026 06:10:00 am
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 02, 2026 06:01:00 am
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
ZYME Stock Data
$1,697,666,774
73,882,368
0.51%
61
N/A
Biotechnology & Life Sciences
Healthcare
CA
Middletown
